Position in ABBV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,226,955
-$471,000 QoQ
Shares Held
28,631
-2.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Parkside Financial Bank & Trust holds $28,780,130 across 15 Drug Manufacturers - General names. ABBV ranks #2 (21.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,749 | $7,127,297 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
28,631 | $6,226,955 | |
| 3 | JNJ |
Johnson & Johnson
|
20,434 | $4,994,886 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,825 | $3,106,488 | |
| 5 | PFE |
Pfizer Inc
|
72,976 | $2,049,165 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
27,005 | $1,637,853 | |
| 7 | AMGN |
Amgen Inc
|
3,990 | $1,403,881 | |
| 8 | NVS |
Novartis AG
|
5,576 | $851,733 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,226,955 | 28,631 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,697,955 | 29,314 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,814,452 | 29,431 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $5,337,502 | 28,755 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,059,240 | 19,374 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $3,076,519 | 17,313 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,341,163 | 16,919 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,800,063 | 16,325 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $2,977,698 | 16,352 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,370,730 | 15,298 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,729,095 | 11,600 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,355,383 | 10,060 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,425,405 | 8,944 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,874,675 | 11,600 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,141,724 | 8,507 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,332,031 | 8,697 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,370,639 | 8,455 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,043,933 | 7,710 | Shares | Defined | 2022-03-01 | |
| 2021-09-30 | $931,672 | 8,637 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $1,540,126 | 13,673 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $1,474,605 | 13,626 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $1,429,809 | 13,344 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,211,457 | 13,831 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $1,293,030 | 13,170 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $817,290 | 10,727 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||